Actinium Pharmaceuticals, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€174.00K - Gross profit
-€174.00K - SG&A expenses
€14.57M - R&D expenses
€23.17M - EBITDA
-€37.39M - D&A
€346.30K - EBIT
-€37.74M - Interest expenses
€0.00 - EBT
-€35.00M - Tax expenses
€0.00 - Net income
-€35.00M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€363.36K - Changes in working capital
-€1.41M - Operating cash flow
-€26.18M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€3.93M - Debt repayment
-€7.68K - Other financing cash flow
€3.93M - Net financing cash flow
€3.92M - Foreign exchange effects
€0.00 - Net change in cash
-€22.26M - Cash at end of period
€51.40M - Free cash flow
-€26.18M
Balance sheet
- Cash and cash equivalents
€51.12M - Cash and short-term investments
€51.12M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€939.10K - Total current assets
€52.05M - Property, plant & equipment
€1.42M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€280.62K - Other non-current assets
€0.00 - Total non-current assets
€1.70M - Total assets
€53.75M - Accounts payable
€6.58M - Short-term debt
€511.77K - Other current liabilities
-€29.85M - Total current liabilities
€7.09M - Long-term debt
€1.18M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€30.44M - Total liabilities
€37.53M - Common stock
€26.44K - Retained earnings
-€340.02M - Other equity
€0.00 - Total equity
€16.22M - Total liabilities and shareholders' equity
€53.75M
Company information
- Market capitalization
€37.78M - Employees
31 - Enterprise Value
-€12.11M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-215.8% Much worse than peer group: -35.0% - ROA
-
-65.1% Much better than peer group: -201.9% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-69.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.13M